FMEA联合PDCA循环管理在重症监护病房多重耐药菌防控中的应用OA
Application of FMEA combined with PDCA cycle management in the prevention and control of multidrug-resistant organism in intensive care unit
目的 探讨基于失效模式与效应分析(FMEA)与PDCA循环管理模式在降低重症监护病房(ICU)多重耐药菌(MDRO)感染中的应用效果.方法 采用前后对照的类实验性研究设计,将2023年3-12月收治的ICU患者设为对照组(n=171),2024年3-12月收治的ICU患者设为干预组(n=162).运用FMEA识别高风险环节(设定风险优先指数RPN≥18为高风险阈值),针对高风险因素制定整改措施,通过PDCA循环实施持续质量改进(每季度复评并动态调整).比较两组患者感染相关核心指标及过程质量指标的变化.结果 RPN平均得分居前两位的风险因素为"手卫生依从性与正确性低"(22.42分)和"对耐药菌患者防护用品使用欠规范"(19.27分),均达到高风险等级(RPN≥18).干预后,两项高风险因素的 RPN值分别下降45.45%、66.06%;医院感染发病率由11.11%降至3.09%(OR=0.26,P=0.005),MDRO 医院感染日发病率由3.95‰降至0.89‰(IRR=0.23,P=0.005);治疗性抗菌药物使用前病原学送检率由89.26%升至97.62%(P=0.009).结论 基于FMEA联合PDCA循环的管理模式能系统识别并干预ICU内 MDRO防控的薄弱环节,有效降低 MDRO感染风险,具有较好的临床推广价值.
Objective To explore the application effect of failure mode and effect analysis(FMEA)combined with PDCA cycle management on reducing multidrug-resistant organism(MDRO)associated infection in the intensive care unit(ICU).Methods A quasi-experimental study with before-after control was carried out.Patients admitted to the ICU from March to December 2023 were assigned to the control group(n=171),and those hospitalized between March and December 2024 served as the intervention group(n=162).FMEA was adopted to identify high-risk links,with risk priority number(RPN)≥18 defined as the threshold for high-risk items.Rectification strategies were formulated for high-risk factors,and continuous quality improvement was implemented via the PDCA cycle.Risk reassessment and dynamic scheme adjustment were performed quarterly.Infection-related core indicators and process quality indicators were compared between the two groups.Results The top two high-risk factors included poor compliance and incorrect operation of hand hygiene(mean RPN=22.42)and nonstandard use of protective equipment for patients colonized or infected with MDROs(mean RPN=19.27),both exceeding the high-risk cut-off(RPN≥18).After intervention,their RPN values decreased by 45.45%and 66.06%,respectively.The overall nosocomial infection incidence dropped from 11.11%to 3.09%(OR=0.26,P=0.005).The MDRO-related healthcare-associated infection incidence per 1 000 patient days decreased from 3.95‰ to 0.89‰(IRR=0.23,P=0.005).The pathogenic specimen submission rate prior to therapeutic antibiotic administration rose from 89.26%to 97.62%(P=0.009).Conclusion The integrated management strategy combining FMEA and the PDCA cycle can systematically identify and intervene in weak points of MDRO prevention in the ICU,and effectively lower the risk of MDRO nosocomial infection,which deserves clinical promotion.
李艳菊;白娜娜;陈永欢
北京市大兴区中西医结合医院院感科,北京 100076北京市大兴区中西医结合医院ICU,北京 100076北京市大兴区中西医结合医院院感科,北京 100076
医药卫生
多重耐药菌失效模式与效应分析PDCA循环医院感染重症监护病房
multidrug-resistant organismsfailure mode and effects analysisPDCA cyclenosocomial infectionintensive care unit
《中国感染控制杂志》 2026 (8)
1233-1241,9
北京市大兴区中西医结合医院院级基金资助项目(DXZXYZ202415)
评论